BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21834821)

  • 1. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
    Saracino A; Kelly R; Liew D; Chong A
    Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
    Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.
    Toyozawa S; Yamamoto Y; Nishide T; Kishioka A; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
    Dermatol Online J; 2008 Nov; 14(11):17. PubMed ID: 19094855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma gangrenosum: a report of 44 cases with follow-up.
    von den Driesch P
    Br J Dermatol; 1997 Dec; 137(6):1000-5. PubMed ID: 9470924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum: an Indian perspective.
    Bhat RM; Nandakishore B; Sequeira FF; Sukumar D; Kamath GH; Martis J; Furtado S
    Clin Exp Dermatol; 2011 Apr; 36(3):242-7. PubMed ID: 21070329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
    Duarte AF; Nogueira A; Lisboa C; Azevedo F
    Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services' Adult Hospital 1998-2009.
    Polcz M; Gu J; Florin T
    J Crohns Colitis; 2011 Apr; 5(2):148-51. PubMed ID: 21453884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum--case report.
    Abela CB; Soldin M; Gateley D
    Br J Oral Maxillofac Surg; 2007 Jun; 45(4):328-30. PubMed ID: 16360244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum and ulcerative colitis in the tropics.
    Alese OB; Irabor DO
    Rev Soc Bras Med Trop; 2008; 41(6):664-7. PubMed ID: 19142449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
    Baglieri F; Scuderi G
    Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of wound breakdown caused by pyoderma gangrenosum after total knee arthroplasty.
    Nakajima N; Ikeuchi M; Izumi M; Kuriyama M; Nakajima H; Tani T
    Knee; 2011 Dec; 18(6):453-5. PubMed ID: 20643552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe pyoderma associated with rheumatoid arthritis].
    Renner R; Sticherling M
    Med Klin (Munich); 2008 Apr; 103(4):251-3. PubMed ID: 18484211
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ulcerative colitis associated with pyoderma gangrenosum].
    Tusnádi A; Uhrin K; Bényei M; Krasznai G
    Orv Hetil; 1994 Apr; 135(17):917-9. PubMed ID: 7909938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum and high titer serum anti-CCP2 antibodies.
    Das SK; Banerjee N; Khaskil S; Mukherjee SS
    JNMA J Nepal Med Assoc; 2012; 52(185):36-9. PubMed ID: 23279772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Treatment-resistant pyoderma gangrenosum.
    Kosari P; Feldman SR
    Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pyoderma gangrenosum with topical factor XIII.
    Hoetzenecker W; Guenova E; Mitev V; Schanz S; Ulmer A; Fierlbeck G
    Eur J Dermatol; 2013; 23(5):653-7. PubMed ID: 24135449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyoderma gangrenosum: report of 11 cases].
    López de Maturana D; Amaro P; Aranibar L; Segovia L
    Rev Med Chil; 2001 Sep; 129(9):1044-50. PubMed ID: 11725468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical negative pressure and skin transplantation for the treatment of pyoderma gangrenosum].
    Gámiz RC; Nielsen AM
    Ugeskr Laeger; 2011 Aug; 173(35):2132-3. PubMed ID: 21884666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series.
    Charles CA; Leon A; Banta MR; Kirsner RS
    Int J Dermatol; 2007 Oct; 46(10):1095-9. PubMed ID: 17910724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.